Delivery Order SPE2DB20D2104-SPE2DB23FR26N
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.85 firm fixed-price delivery order is for the supply of Belsomra 10 mg tablets, a medication used to treat insomnia. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.28 firm fixed-price contract is for the supply of Belsomra 10mg tablets, a prescription medication used to treat insomnia. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,527.84 Firm Fixed Price Delivery Order is for the supply of Belsomra 20 mg tablets, a medication used to treat insomnia. The contract has a completion date of November 5, 2024 and was awarded on November 4, 2024. The place of performance is Conshohocken, PA. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,866.59 Firm Fixed Price Delivery Order provides Belsomra 10 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for delivering a wide...
- This federal contract award, valued at $1,185.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELSOMRA 10 MG TABLET 30S, a prescription medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FEZK4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Belsomra 20 mg tablets in 30-count packages, with a ceiling value of $1,533.44 and a completion date of June 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Belsomra 20 mg tablets (30-count units) under a firm fixed-price contract valued at $1,488.99. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply to...
- This federal contract award, valued at $1,072.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELSOMRA 20 MG TABLET 30S, a prescription medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Belsomra 20 mg tablets (30-count units) valued at $1,706.39. This firm fixed-price delivery order, which carries an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply agreement extending through...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN64D, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,740.54 firm fixed-price delivery order contract is for the supply of BELSOMRA 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR26NDelivery Order
This federal contract award, valued at $1,382.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Belsomra 20 mg tablets, a prescription medication used to treat insomnia. The contract has a firm fixed price and an ultimate completion date of December 1, 2022. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/30/22 |